Literature DB >> 1829411

Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta.

M Turner1, D Chantry, P Katsikis, A Berger, F M Brennan, M Feldmann.   

Abstract

Transforming growth factor-beta 1 (TGF-beta 1) mediates many immunosuppressive effects on immune cells and can inhibit the production of tumor necrosis factor and interleukin 1 (IL 1). However, TGF-beta 1 can stimulate the production of IL 6 and platelet-derived growth factor, indicating that TGF-beta 1 initiates complex effects on the production of cytokines. In this report we show that treatment of peripheral blood monocytes with TGF-beta 1 leads to the induction of a recently described IL 1 receptor antagonist protein (IRAP). The effect of TGF-beta 1 was both dose and time dependent. TGF-beta 1 induced de novo synthesis of IRAP, as Northern blotting experiments indicated a rapid and transient induction of the mRNA encoding IRAP. The induction of IRAP suggests a potential mechanism by which some of the inhibitory effects of TGF-beta 1 are mediated.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1829411     DOI： 10.1002/eji.1830210708

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


  30 in total

Review 1.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

2.  Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo.

Authors:  H M van Beuningen; P M van der Kraan; O J Arntz; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

3.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 4.  Cytokines in rheumatoid arthritis.

Authors:  F A Houssiau
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

5.  Effect of neutralizing transforming growth factor beta1 on the immune response against Mycobacterium tuberculosis in guinea pigs.

Authors:  Shannon Sedberry Allen; Lynne Cassone; Todd M Lasco; David N McMurray
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 6.  Basic biology and role of interleukin-17 in immunity and inflammation.

Authors:  Camille Zenobia; George Hajishengallis
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

7.  Transforming growth factor beta in normal human lung: preferential location in bronchial epithelial cells.

Authors:  A Magnan; I Frachon; B Rain; M Peuchmaur; G Monti; B Lenot; M Fattal; G Simonneau; P Galanaud; D Emilie
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

8.  Inhibition of the acute-phase response in a human hepatoma cell line.

Authors:  J G Raynes; S Bevan
Journal:  Agents Actions       Date:  1993

9.  Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1.

Authors:  F A Offner; H Feichtinger; S Stadlmann; P Obrist; C Marth; P Klingler; B Grage; M Schmahl; C Knabbe
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

10.  Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses.

Authors:  Philip T Liu; Mirjam Schenk; Valencia P Walker; Paul W Dempsey; Melissa Kanchanapoomi; Matthew Wheelwright; Aria Vazirnia; Xiaoran Zhang; Andreas Steinmeyer; Ulrich Zügel; Bruce W Hollis; Genhong Cheng; Robert L Modlin
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.